A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott(Brigham and Women's Hospital), Siwen Hu‐Lieskovan(University of California, Los Angeles), Bartosz Chmielowski(University of California, Los Angeles), Ramaswamy Govindan(Washington University in St. Louis), Aung Naing(The University of Texas MD Anderson Cancer Center), Nina Bhardwaj(Tisch Hospital), Kim Margolin(City Of Hope National Medical Center), Mark M. Awad(Brigham and Women's Hospital), Matthew D. Hellmann(Memorial Sloan Kettering Cancer Center), Jessica J. Lin(Harvard University), Terence W. Friedlander(University of California, San Francisco), Meghan E. Bushway(BioNTech (United States)), Kristen N. Balogh(BioNTech (United States)), Tracey Sciuto(BioNTech (United States)), Victoria Kohler(BioNTech (United States)), Samantha Jane Turnbull(BioNTech (United States)), Rana H. Besada(BioNTech (United States)), Riley R. Curran(BioNTech (United States)), Benjamin Trapp(BioNTech (United States)), Julian Scherer(BioNTech (United States)), Asaf Poran(BioNTech (United States)), Dewi Harjanto(BioNTech (United States)), Dominik Barthelme(BioNTech (United States)), Ying S. Ting(BioNTech (United States)), Jesse Z. Dong(BioNTech (United States)), Yvonne Ware(BioNTech (United States)), Yu-Ting Huang(BioNTech (United States)), Zhengping Huang(BioNTech (United States)), Amy Wanamaker(BioNTech (United States)), Lisa D. Cleary(BioNTech (United States)), Melissa A. Moles(BioNTech (United States)), Kelledy Manson(BioNTech (United States)), Joel Greshock(BioNTech (United States)), Zakaria Khondker(BioNTech (United States)), Ed Fritsch(BioNTech (United States)), Michael S. Rooney(BioNTech (United States)), Mark DeMario(BioNTech (United States)), Richard B. Gaynor(BioNTech (United States)), Lakshmi Srinivasan(BioNTech (United States))
Cited by 735Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis